+39 02 610346.1 - info@newron.com

Press Releases

Filter by year
  • march272018

    Shareholders accepted all motions at the AGM 2018

     

  • march12018

    Newron announces 2017 financial results and provides outlook for 2018

     

  • february132018

    Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies

     

  • february82018

    Change in the Board of Directors

     

  • february12018

    Primary endpoint met in phase II/III clinical study of investigational Parkinson’s disease treatment safinamide in Japan